Last Updated: September 24, 2026

Hospira Inc Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for HOSPIRA INC

HOSPIRA INC has fifty-one approved drugs.

There are three tentative approvals on HOSPIRA INC drugs.

Summary for Hospira Inc

US Patents:	0
Tradenames:	42
Ingredients:	33
NDAs:	51
Patent Litigation for Hospira Inc:	See patent lawsuits for Hospira Inc

Drugs and US Patents for Hospira Inc

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Hospira Inc	MIDAZOLAM HYDROCHLORIDE	midazolam hydrochloride	INJECTABLE;INJECTION	075409-002	Jun 20, 2000		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Hospira Inc	CEFOXITIN	cefoxitin sodium	INJECTABLE;INJECTION	065313-002	Jan 23, 2006		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Hospira Inc	THEOPHYLLINE IN DEXTROSE 5% IN PLASTIC CONTAINER	theophylline	INJECTABLE;INJECTION	019211-006	Jan 20, 1988		DISCN	Yes	No		⤷ Start Trial				⤷ Start Trial
Hospira Inc	AMPICILLIN AND SULBACTAM	ampicillin sodium; sulbactam sodium	INJECTABLE;INJECTION	090375-001	Dec 21, 2011		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Hospira Inc	HYDROMORPHONE HYDROCHLORIDE	hydromorphone hydrochloride	INJECTABLE;INJECTION	200403-005	Mar 3, 2023		RX	No	No		⤷ Start Trial				⤷ Start Trial
Hospira Inc	CEFTRIAXONE	ceftriaxone sodium	INJECTABLE;INTRAMUSCULAR, INTRAVENOUS	065230-001	Aug 2, 2005		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Hospira Inc	GEMCITABINE HYDROCHLORIDE	gemcitabine hydrochloride	INJECTABLE;INJECTION	079183-001	Nov 15, 2010	AP	RX	No	Yes		⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for Hospira Inc

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Hospira Inc	NIPENT	pentostatin	INJECTABLE;INJECTION	020122-001	Oct 11, 1991	3,923,785	⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.